中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2013年
7期
1225-1226
,共2页
尿激酶%左旋精氨酸%心肌梗死
尿激酶%左鏇精氨痠%心肌梗死
뇨격매%좌선정안산%심기경사
Urokinase%L-arginine%Myocardial infarction
目的:对用尿激酶溶栓联合左旋精氨酸治疗急性ST段抬高型心肌梗死(MI)疾病的疗效加以分析。方法:将我院的76例ST段抬高型MI患者随机均分为两组,尿激酶组采用尿激酶溶栓加上左旋精氨酸共同治疗,常规组采用常规的溶栓来治疗,对两组患者的血管再通情况,乳酸脱氢酶、超氧化物歧化酶、肌钙蛋白、肌酸激酶含量,两组患者的不良反应率加以分析。结果:尿激酶组的血管的再通率略高于常规组,且通血时间段也略高于常规组,但P>0.05,差异不具有显著意义。尿激酶组的各种酶含量也优于常规组,P<0.05。尿激酶组的不良反应率低于常规组的不良反应率,P<0.05。结论:尿激酶溶栓加上左旋精氨酸联合治疗急性ST段抬高型MI疾病可提高患者的通血率,不良反应小,对MI具有很好的保护作用。
目的:對用尿激酶溶栓聯閤左鏇精氨痠治療急性ST段抬高型心肌梗死(MI)疾病的療效加以分析。方法:將我院的76例ST段抬高型MI患者隨機均分為兩組,尿激酶組採用尿激酶溶栓加上左鏇精氨痠共同治療,常規組採用常規的溶栓來治療,對兩組患者的血管再通情況,乳痠脫氫酶、超氧化物歧化酶、肌鈣蛋白、肌痠激酶含量,兩組患者的不良反應率加以分析。結果:尿激酶組的血管的再通率略高于常規組,且通血時間段也略高于常規組,但P>0.05,差異不具有顯著意義。尿激酶組的各種酶含量也優于常規組,P<0.05。尿激酶組的不良反應率低于常規組的不良反應率,P<0.05。結論:尿激酶溶栓加上左鏇精氨痠聯閤治療急性ST段抬高型MI疾病可提高患者的通血率,不良反應小,對MI具有很好的保護作用。
목적:대용뇨격매용전연합좌선정안산치료급성ST단태고형심기경사(MI)질병적료효가이분석。방법:장아원적76례ST단태고형MI환자수궤균분위량조,뇨격매조채용뇨격매용전가상좌선정안산공동치료,상규조채용상규적용전래치료,대량조환자적혈관재통정황,유산탈경매、초양화물기화매、기개단백、기산격매함량,량조환자적불량반응솔가이분석。결과:뇨격매조적혈관적재통솔략고우상규조,차통혈시간단야략고우상규조,단P>0.05,차이불구유현저의의。뇨격매조적각충매함량야우우상규조,P<0.05。뇨격매조적불량반응솔저우상규조적불량반응솔,P<0.05。결론:뇨격매용전가상좌선정안산연합치료급성ST단태고형MI질병가제고환자적통혈솔,불량반응소,대MI구유흔호적보호작용。
Objective:To use of thrombolytic therapy with urokinase plus L-arginine to treatment of acute ST segment elevation myocardial infarction disease's curative effect analysis.Methods:Visit to our hospital 76 cases of ST segment elevation myocardial infarction were randomly divided into two groups,the UK group treated by urokinase plus L-arginine common treatment,conventional group using conventional thrombolytic treatment,two groups of patients with blood vessel recanalization,lactate dehydrogenase,superoxide dismutase,troponin,creatine kinase content,two groups of patients with adverse reaction rate analysis.Results:The UK group vascular recanalization rate slightly higher than the conventional group,and through blood time period is also slightly higher than the conventional group,but P>0.05,the difference is not significant.The UK group of various enzyme content also is superior to the conventional group,P<0.05.The UK group the rate of adverse reactions is lower than that of conventional group the rate of adverse reactions,P<0.05. Conclusion:The use of thrombolytic therapy with urokinase plus L arginine in the treatment of acute ST segment elevation myocardial infarction disease may improve the patient's blood rate, adverse reactions,on myocardial infarction has good protection action.